Total Funding
63
70
Total FundingSeries A raised
Growth Score
-3 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
7114
A clinical stage drug development company who aims to invent novel drugs for hard-to-treat diseases using its proprietary AI platform
Andy Protter: Chief Scientific Officer- Viwat Visuthikraisee: Co-Founder, COO
About the Company
Auransa is a clinical stage drug development company who aims to invent high value, novel drugs for hard-to-treat diseases like cancer, auto-immune and neurological disorders using its proprietary AI platform and drug discovery expertise. The company's platform is used to understand biology of diseases at subtype level resolution, enabling it
to predict compounds and targets of novel pharmacology for responder patient population. Current internal drug pipeline includes a first-in-class investigational new drug for cancer in clinical trials. Auransa has partnership with companies and institutions in the biopharma industry.
East Asian Founded
East Asian Led
Southeast Asian Founded
Southeast Asian Led
Women Founded
Women Led
